Comments for OPK - Stockpickr! Your Source for Stock Ideas

Comments for OPK

Added By	Comments	Type	Date Added
Wayniac	Has a drug in Phase III	Love	January 19, 2009
mrawlejr	Biotech	Love	September 12, 2008
ms	The Frost Gamma Trust, an investment vehicle managed by the company’s CEO, Miami billionaire Dr. Phillip Frost, bought $20M in shares, bringing its holdings up to 62%. Opko is developing Bevasiranib, a small interfering RNA (siRNA) drug designed to silence the genes that produce vascular endothelial growth factor (VEGF), believed to be largely responsible for the vision loss of wet AMD. If anyone has a bead on the value of this drug, send me an email.	Love	December 09, 2007
Ktulu	OPK's drug (Bevasiranib) for wet AMD uses RNAi to turn off blood vessal growth in the eye. RNAi is a very promissing technology. This drug should be much mre effective than Genentech's Lucentis for treating wet AMD.	Love	September 27, 2007
hunza	phase three almost complete .looking for positive results.big inside buying.target 15.00	Love	September 06, 2007
Barrons	Six directors and officers recently purchased 1,375,000 shares or $5,308,000 worth of stock.	Love	July 21, 2007